These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23945276)

  • 1. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.
    Pegoraro S; Ros G; Piazza S; Sommaggio R; Ciani Y; Rosato A; Sgarra R; Del Sal G; Manfioletti G
    Oncotarget; 2013 Aug; 4(8):1293-308. PubMed ID: 23945276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
    Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
    Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc.
    Li Z; Liu J; Chen T; Sun R; Liu Z; Qiu B; Xu Y; Zhang Z
    J Exp Clin Cancer Res; 2021 Mar; 40(1):86. PubMed ID: 33648560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
    Di Cello F; Shin J; Harbom K; Brayton C
    Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
    Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
    Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
    Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
    Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
    Huang R; Huang D; Dai W; Yang F
    Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1.
    Yin P; Bai Y; Wang Z; Sun Y; Gao J; Na L; Zhang Z; Wang W; Zhao C
    Cell Commun Signal; 2020 Sep; 18(1):143. PubMed ID: 32894152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
    Puca F; Colamaio M; Federico A; Gemei M; Tosti N; Bastos AU; Del Vecchio L; Pece S; Battista S; Fusco A
    Oncotarget; 2014 May; 5(10):3234-45. PubMed ID: 24833610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
    Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
    Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
    Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
    Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.